791 animalsOverall, 791 animals from Ebonyi, Ogun, Ondo, and Oyo States, Nigeria were screened for SARS-CoV-2.
NigeriaCOVID-19publié 2023Viruseseurope_pmcdocument de 6 observationsDOI 10.3390/v15051187
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
209 evidences · page 7 / 9
791 animalsOverall, 791 animals from Ebonyi, Ogun, Ondo, and Oyo States, Nigeria were screened for SARS-CoV-2.
NigeriaCOVID-19publié 2023Viruseseurope_pmcdocument de 6 observationsDOI 10.3390/v15051187
8,12 odds_ratioAfter multivariable adjustment, the odds of pre-DM were 8.12 higher in those with a history of COVID-19 compared to controls.
NigeriaCOVID-19 · pre-diabetespublié 2024BMC public healthPubMeddocument de 10 observations
84 414 casesAs of December 2020, approximately 84,414 cases of COVID-19 were identified in Nigeria.
NigeriaCOVID-19observé December 2020HAL · Unilimdocument de 63 observations
1 254 deathsAs of December 2020, 1,254 deaths from COVID-19 were reported in Nigeria.
NigeriaCOVID-19observé December 2020HAL · Unilimdocument de 63 observations
26,2 %Hypertension prevalence was 26.2% among RT-PCR-negative patients and 21.0% among RT-PCR-positive patients.
NigeriaCOVID-19 · hypertension artérielleobservé 27 February 2020 to 30 September 2020publié 2021The Nigerian postgraduate medical journalPubMeddocument de 12 observations
1,3 DOT_per_LOTPatients with severe COVID-19 had a mean days of therapy per length of therapy (DOT per LOT) of 1.3.
NigeriaCOVID-19HAL · Unilimdocument de 63 observations
1,2 DOT_per_LOTPatients with mild COVID-19 received antimicrobial therapy with a mean DOT per LOT of 1.2 compared to 1.4 and 1.3 for moderate and severe patients respectively.
NigeriaCOVID-19HAL · Unilimdocument de 63 observations
95,2 %95.2% of participants reported distrust in vaccine safety as a barrier to COVID-19 vaccine uptake.
NigeriaCOVID-19observé April-June 2024publié 2026Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument de 8 observations
2,3 %Cancer prevalence was 2.3% among RT-PCR-negative patients and 0.5% among RT-PCR-positive patients.
Nigeriacancer (non précisé) · COVID-19observé 27 February 2020 to 30 September 2020publié 2021The Nigerian postgraduate medical journalPubMeddocument de 12 observations
48 facilitiesBetween September 2022 and February 2023, 48 Community Pharmacies, 21 Patent Medicine Stores, and 79 Primary Health Centers were evaluated for COVID-19 antigen rapid diagnostic testing quality in the Federal Capital Territory of Nigeria.
NigeriaCOVID-19observé September 2022 to February 2023publié 2024PloS onePubMeddocument de 5 observations
59 287 casesAs of 4th October 2020, Nigeria had 59 287 confirmed cases of COVID-19.
NigeriaCOVID-19observé 4th October 2020publié 2021Journal of primary care & community healthPubMeddocument de 3 observations
4,54 aORAge ≥ 50 years was associated with increased odds of severe SARS-CoV-2 disease (adjusted odds ratio 4.54, 95% CI: 1.86–11.08).
NigeriaCOVID-19observé April to July 2020publié 2022The Pan African medical journalPubMeddocument de 13 observations
SARS-CoV-2 RNA was detected in almost all animal taxa and sampling locations except Oyo State.
NigeriaCOVID-19publié 2023Viruseseurope_pmcdocument de 6 observationsDOI 10.3390/v15051187
271 patientsThe sample size for the study was 271 hospitalized COVID-19 patients.
NigeriaCOVID-19HAL · Unilimdocument de 63 observations
6 patientsSix patients presented with de novo heart failure.
NigeriaCOVID-19 · insuffisance cardiaquepublié 2021Cardiovascular journal of AfricaPubMeddocument de 8 observations
25 %Another study found that spraying resulted in 25.0% surface contamination (n = 12/48) compared to 48.2% (n = 13/27) with wiping.
NigeriaCOVID-19publié 2025Journal of public health in Africaeurope_pmcdocument de 3 observations
70 %More than 70% of confirmed COVID-19 cases in Nigeria were concentrated in 7 States: Lagos, Abuja, Oyo, Kano, Edo, Rivers and Delta.
NigeriaCOVID-19publié 2020The Pan African medical journalPubMeddocument de 6 observations
0,2 correlation_coefficientThere is a positive relationship between knowledge of COVID-19 and attitude to guidelines (R = 0.20; p < 0.05).
NigeriaCOVID-19publié 2022The Pan African medical journalPubMeddocument de 10 observations
67,4 %Fever was noted in 67.4% of patients.
NigeriaCOVID-19publié 2022West African journal of medicinePubMeddocument de 15 observations
12 000 casesBy the next three months after 27 February 2020, more than 12,000 cases of COVID-19 were identified in Nigeria.
NigeriaCOVID-19observé three months after 27 February 2020HAL · Unilimdocument de 63 observations
43,5 %Pfizer-BioNTech was the most administered COVID-19 vaccine, accounting for 43.5% of doses.
NigeriaCOVID-19observé April-June 2024publié 2026Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument de 8 observations
38 %Among the 45 COVID-19 patients, 38% presented with fever.
NigeriaCOVID-19observé 2020publié 2020The American journal of tropical medicine and hygieneeurope_pmcdocument de 8 observations
19 monthsThe median time interval between COVID-19 diagnosis and the glycaemic assessment was 19 months.
NigeriaCOVID-19publié 2024BMC public healthPubMeddocument de 10 observations
87,8 %Among community health workers in selected States of Nigeria, 87.80% have good knowledge of COVID-19.
NigeriaCOVID-19publié 2022The Pan African medical journalPubMeddocument de 10 observations
1,74 aORAttendance of mass gatherings was associated with increased odds of SARS-CoV-2 infection (adjusted odds ratio 1.74, 95% CI: 1.10–2.74).
NigeriaCOVID-19observé April to July 2020publié 2022The Pan African medical journalPubMeddocument de 13 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.